Learn more about Elegen’s superior ability to produce high-complexity DNA sequences that conventional methods struggle with. Our novel assembly method minimizes hybridization errors during polymerase chain assembly (PCA), enabling the successful synthesis of sequences rich in GC-rich elements, long repeats, and other challenging structures that are frequently rejected by competitors, including:
Internal testing demonstrates significantly improved synthesis success rates (92%) compared to leading competitors (≤58%), validating ENFINIA’s ability to handle previously unsynthesizable sequences, such as those found in antibody expression constructs and various promoters.
Subscribe to our latest news and product updates. (enter work email address only).
Elegen Corp
3565 Haven Ave, Suite 3
Menlo Park, CA 94025
© 2025 Elegen Corporation. All Rights Reserved.